Sign Out
Known hypersensitivity to basiliximab or any other component of Simulect.
Use in pregnancy & lactation: Simulect is contraindicated during pregnancy and lactation. Basiliximab has potentially hazardous pharmacological effects with respect to the course of gestation and the suckling neonate exposed to basiliximab in breast milk. This concern is based on basiliximab's immunosuppressive action. Women of childbearing potential must use adequate contraception to prevent pregnancy and continue its use for an additional 8 weeks after the last dose of Simulect.
Lanjutkan dengan Google